- $4.37m
- $1.59m
- $9.29m
- 32
- 44
- 18
- 21
Annual balance sheet for iSpecimen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.696 | 27.7 | 15.3 | 5.01 | 1.88 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.36 | 4.88 | 4.07 | 2.94 | 1.44 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3.47 | 32.9 | 19.7 | 8.24 | 3.59 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.076 | 0.033 | 0.411 | 0.322 | 0.422 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 6.21 | 35.7 | 24.6 | 15.8 | 9.35 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 22.1 | 2.51 | 4.28 | 6.05 | 5.77 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 22.3 | 5.93 | 4.31 | 6.08 | 6.04 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | -16.1 | 29.8 | 20.3 | 9.74 | 3.31 |
| Total Liabilities & Shareholders' Equity | 6.21 | 35.7 | 24.6 | 15.8 | 9.35 |
| Total Common Shares Outstanding |